Ratings by BofA Securities (Travis Steed)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/12/2026 | AxoGen, Inc. | AXGN | New Coverage | Buy (N/A) |
36.13 (38.06) |
5.34% | Details | |
| 9/2/2026 | MiniMed Group | MMED | Maintain | Buy (N/A) |
|
Details | ||
| 9/2/2026 | Medtronic, Inc. | MDT | Maintain | Buy (N/A) |
|
Details | ||
| 8/12/2026 | Merit Medical Systems, Inc. | MMSI | Maintain | Neutral (N/A) |
|
Details | ||
| 8/10/2026 | MiniMed Group | MMED | Maintain | Buy (N/A) |
|
Details | ||
| 6/29/2026 | CONMED | CNMD | Downgrade | Underperform (Neutral) |
35.95 (49.25) |
37% | Details | |
| 6/2/2026 | Mobia Medical | MOBI | New Coverage | Buy (N/A) |
13.50 (10.41) |
-22.89% | Details | |
| 5/22/2026 | Inspire Medical Systems | INSP | Downgrade | Neutral (Buy) |
44.74 (71.11) |
58.94% | Details | |
| 5/18/2026 | DexCom | DXCM | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2026 | Inspire Medical Systems | INSP | Downgrade | Neutral (Buy) |
54.84 (44.74) |
-18.42% | Details | |
| 4/24/2026 | Edwards Lifesciences | EW | Maintain | Buy (N/A) |
|
Details | ||
| 4/22/2026 | Beta Bionics, Inc. | BBNX | Maintain | Neutral (N/A) |
|
Details | ||
| 4/17/2026 | Abbott Labs | ABT | Maintain | Buy (N/A) |
|
Details | ||
| 3/31/2026 | MiniMed Group | MMED | New Coverage | Buy (N/A) |
14.35 (18.34) |
27.8% | Details | |
| 3/23/2026 | Medtronic, Inc. | MDT | Maintain | Buy (N/A) |
|
Details | ||
| 3/16/2026 | Baxter International | BAX | Maintain | Neutral (N/A) |
|
Details | ||
| 2/20/2026 | Tandem Diabetes Care | TNDM | Upgrade | Neutral (Underperform) |
18.52 (17.43) |
-5.89% | Details | |
| 1/9/2026 | Beta Bionics, Inc. | BBNX | Downgrade | Neutral (Buy) |
31.49 (19.16) |
-39.16% | Details | |
| 11/17/2025 | Masimo Corp. | MASI | New Coverage | Neutral (N/A) |
151.12 (179.95) |
19.08% | Details | |
| 11/7/2025 | Globus Medical | GMED | Upgrade | Buy (Neutral) |
61.51 (81.41) |
32.35% | Details | |
| 7/23/2025 | Boston Scientific | BSX | Maintain | Buy (N/A) |
|
Details | ||
| 7/11/2025 | Medtronic, Inc. | MDT | Maintain | Buy (N/A) |
|
Details | ||
| 7/7/2025 | Baxter International | BAX | Maintain | Neutral (N/A) |
|
Details | ||
| 6/25/2025 | Boston Scientific | BSX | Maintain | Buy (N/A) |
|
Details | ||
| 5/29/2025 | Embecta | EMBC | Maintain | Underperform (N/A) |
|
Details | ||
| 5/1/2025 | Becton Dickinson | BDX | Downgrade | Neutral (Buy) |
207.09 (198.91) |
-3.95% | Details | |
| 3/31/2025 | Kestra Medical Technologies | KMTS | New Coverage | Buy (N/A) |
23.43 (28.76) |
22.75% | Details | |
| 3/14/2025 | Abbott Labs | ABT | Maintain | Buy (N/A) |
|
Details | ||
| 3/14/2025 | Penumbra | PEN | New Coverage | Buy (N/A) |
260.63 (324.39) |
24.46% | Details | |
| 3/10/2025 | Axonics Modulation Technologies Inc. | AXNX | Maintain | Buy (N/A) |
|
Details | ||
| 3/10/2025 | Abbott Labs | ABT | Maintain | Buy (N/A) |
|
Details | ||
| 2/24/2025 | Beta Bionics, Inc. | BBNX | New Coverage | Buy (N/A) |
20.57 (31.49) |
53.09% | Details | |
| 2/10/2025 | DexCom | DXCM | Maintain | Buy (N/A) |
|
Details | ||
| 2/5/2025 | Boston Scientific | BSX | Maintain | Buy (N/A) |
|
Details | ||
| 1/7/2025 | Stryker | SYK | Maintain | Buy (N/A) |
|
Details | ||
| 12/16/2024 | Edwards Lifesciences | EW | Upgrade | Buy (Neutral) |
73.32 (89.07) |
21.48% | Details | |
| 11/25/2024 | DexCom | DXCM | Maintain | Buy (N/A) |
|
Details | ||
| 11/20/2024 | Inspire Medical Systems | INSP | Upgrade | Buy (Neutral) |
176.05 (54.84) |
-68.85% | Details | |
| 11/5/2024 | Ceribell | CBLL | New Coverage | Buy (N/A) |
26.24 (27.13) |
3.39% | Details | |
| 10/30/2024 | Edwards Lifesciences | EW | Maintain | Neutral (N/A) |
|
Details | ||
| 10/4/2024 | Baxter International | BAX | Maintain | Neutral (N/A) |
|
Details | ||
| 9/27/2024 | Boston Scientific | BSX | Maintain | Buy (N/A) |
|
Details | ||
| 7/25/2024 | Edwards Lifesciences | EW | Downgrade | Neutral (Buy) |
86.95 (89.07) |
2.44% | Details | |
| 6/3/2024 | Inspire Medical Systems | INSP | Maintain | Neutral (N/A) |
|
Details | ||
| 5/13/2024 | Nevro Corp | NVRO | Maintain | Neutral (N/A) |
|
Details | ||
| 5/10/2024 | Solventum | SOLV | New Coverage | Neutral (N/A) |
64.83 (85.41) |
31.74% | Details | |
| 5/8/2024 | Inspire Medical Systems | INSP | Downgrade | Neutral (Buy) |
245.63 (71.11) |
-71.05% | Details | |
| 3/20/2024 | Shockwave Medical | SWAV | Maintain | Buy (N/A) |
|
Details | ||
| 3/7/2024 | Edwards Lifesciences | EW | Upgrade | Buy (Neutral) |
88.33 (89.07) |
0.84% | Details | |
| 3/5/2024 | Baxter International | BAX | Maintain | Buy (N/A) |
|
Details | ||
| 2/7/2024 | Inspire Medical Systems | INSP | Maintain | Buy (N/A) |
|
Details | ||
| 2/7/2024 | Edwards Lifesciences | EW | Maintain | Neutral (N/A) |
|
Details | ||
| 10/26/2023 | Edwards Lifesciences | EW | Maintain | Neutral (N/A) |
|
Details | ||
| 10/13/2023 | Outset Medical Inc. | OM | Downgrade | Underperform (Buy) |
6.77 (4.10) |
-39.44% | Details | |
| 9/5/2023 | Stryker | SYK | Upgrade | Buy (Neutral) |
284.45 (307.15) |
7.98% | Details | |
| 8/24/2023 | Insulet Corporation | PODD | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2023 | Becton Dickinson | BDX | Maintain | Buy (N/A) |
|
Details | ||
| 7/24/2023 | CONMED | CNMD | Maintain | Neutral (N/A) |
|
Details | ||
| 7/21/2023 | Intuitive Surgical | ISRG | Maintain | Buy (N/A) |
|
Details | ||
| 7/12/2023 | Silk Road Medical | SILK | Downgrade | Underperform (Buy) |
32.65 (27.49) |
-15.8% | Details | |
| 7/5/2023 | Inspire Medical Systems | INSP | Maintain | Buy (N/A) |
|
Details | ||
| 5/16/2023 | Boston Scientific | BSX | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2023 | Tandem Diabetes Care | TNDM | Downgrade | Underperform (Neutral) |
37.51 (18.52) |
-50.63% | Details | |
| 5/4/2023 | Inari Medical Inc. | NARI | Maintain | Buy (N/A) |
|
Details | ||
| 5/3/2023 | Zimmer Biomet | ZBH | Upgrade | Neutral (Underperform) |
143.01 (98.56) |
-31.08% | Details | |
| 4/19/2023 | Intuitive Surgical | ISRG | Maintain | Buy (N/A) |
|
Details | ||
| 4/17/2023 | Medtronic, Inc. | MDT | Maintain | Buy (N/A) |
|
Details | ||
| 4/11/2023 | Shockwave Medical | SWAV | Maintain | Buy (N/A) |
|
Details | ||
| 2/2/2023 | Boston Scientific | BSX | Maintain | Buy (N/A) |
|
Details | ||
| 1/3/2023 | Pulmonx Corp. | LUNG | Downgrade | Underperform (Neutral) |
8.43 (1.83) |
-78.29% | Details | |
| 1/3/2023 | Becton Dickinson | BDX | Upgrade | Buy (Neutral) |
254.30 (207.09) |
-18.56% | Details | |
| 1/3/2023 | Baxter International | BAX | Downgrade | Neutral (Buy) |
50.97 (25.30) |
-50.36% | Details | |
| 11/23/2022 | Medtronic, Inc. | MDT | Maintain | Buy (N/A) |
|
Details | ||
| 11/22/2022 | Silk Road Medical | SILK | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2022 | Tandem Diabetes Care | TNDM | Maintain | Neutral (N/A) |
|
Details | ||
| 11/8/2022 | Shockwave Medical | SWAV | Maintain | Buy (N/A) |
|
Details | ||
| 7/21/2022 | Abbott Labs | ABT | Maintain | Buy (N/A) |
|
Details | ||
| 7/11/2022 | Stryker | SYK | Downgrade | Neutral (Buy) |
200.88 (307.15) |
52.9% | Details | |
| 7/6/2022 | Intuitive Surgical | ISRG | Maintain | Buy (N/A) |
|
Details | ||
| 6/22/2022 | Baxter International | BAX | Maintain | Buy (N/A) |
|
Details | ||
| 6/21/2022 | Embecta | EMBC | New Coverage | Underperform (N/A) |
28.26 (6.71) |
-76.26% | Details | |
| 5/31/2022 | Abbott Labs | ABT | Maintain | Buy (N/A) |
|
Details | ||
| 5/27/2022 | Medtronic, Inc. | MDT | Maintain | Buy (N/A) |
|
Details | ||
| 5/23/2022 | Medtronic, Inc. | MDT | Maintain | Buy (N/A) |
|
Details | ||
| 3/23/2022 | Inari Medical Inc. | NARI | New Coverage | Buy (N/A) |
86.17 (79.97) |
-7.2% | Details | |
| 3/2/2022 | Cardiovascular Systems | CSII | New Coverage | Underperform (N/A) |
21.63 (20.00) |
-7.54% | Details | |
| 3/2/2022 | Tandem Diabetes Care | TNDM | New Coverage | Neutral (N/A) |
112.96 (17.43) |
-84.57% | Details | |
| 3/2/2022 | Pulmonx Corp. | LUNG | New Coverage | Neutral (N/A) |
26.56 (1.83) |
-93.11% | Details | |
| 3/2/2022 | CONMED | CNMD | New Coverage | Neutral (N/A) |
144.55 (49.25) |
-65.93% | Details | |
| 3/2/2022 | Insulet Corporation | PODD | New Coverage | Buy (N/A) |
260.84 (149.01) |
-42.87% | Details | |
| 3/2/2022 | Shockwave Medical | SWAV | New Coverage | Buy (N/A) |
178.80 (334.75) |
87.22% | Details | |
| 3/2/2022 | Outset Medical Inc. | OM | New Coverage | Buy (N/A) |
43.61 (4.10) |
-90.6% | Details | |
| 3/2/2022 | Inspire Medical Systems | INSP | New Coverage | Buy (N/A) |
242.30 (71.11) |
-70.65% | Details | |
| 3/2/2022 | DexCom | DXCM | New Coverage | Buy (N/A) |
408.41 (77.94) |
-80.92% | Details | |
| 3/2/2022 | Axonics Modulation Technologies Inc. | AXNX | New Coverage | Buy (N/A) |
57.38 (1.01) |
-98.24% | Details | |
| 3/2/2022 | Zimmer Biomet | ZBH | New Coverage | Underperform (N/A) |
123.39 (143.01) |
15.9% | Details | |
| 3/2/2022 | Edwards Lifesciences | EW | New Coverage | Neutral (N/A) |
112.37 (89.07) |
-20.74% | Details | |
| 3/2/2022 | Becton Dickinson | BDX | New Coverage | Neutral (N/A) |
271.28 (198.91) |
-26.68% | Details | |
| 3/2/2022 | Stryker | SYK | New Coverage | Buy (N/A) |
263.35 (307.15) |
16.63% | Details | |
| 3/2/2022 | Medtronic, Inc. | MDT | New Coverage | Buy (N/A) |
104.99 (95.41) |
-9.12% | Details | |
| 3/2/2022 | Intuitive Surgical | ISRG | New Coverage | Buy (N/A) |
290.33 (452.29) |
55.78% | Details | |
| 3/2/2022 | Boston Scientific | BSX | New Coverage | Buy (N/A) |
44.17 (45.69) |
3.44% | Details | |
| 3/2/2022 | Baxter International | BAX | New Coverage | Buy (N/A) |
84.97 (25.30) |
-70.22% | Details | |
| 3/2/2022 | Abbott Labs | ABT | New Coverage | Buy (N/A) |
120.62 (103.70) |
-14.03% | Details | |
| 1/6/2021 | DexCom | DXCM | Downgrade | Underperform (Buy) |
368.75 (77.94) |
-78.86% | Details | |
| 6/17/2020 | DexCom | DXCM | Maintain | Buy (N/A) |
|
Details | ||
| 12/18/2019 | DexCom | DXCM | Maintain | Buy (N/A) |
|
Details | ||
| 6/7/2019 | DexCom | DXCM | Maintain | Buy (N/A) |
|
Details | ||
| 9/20/2018 | Tandem Diabetes Care | TNDM | Maintain | Neutral (N/A) |
|
Details | ||
| 8/24/2018 | Tandem Diabetes Care | TNDM | Upgrade | Neutral (Underperform) |
38.61 (17.43) |
-54.86% | Details |
